Elanco Animal Health Incorporated
ELAN
$24.88
-$1.21-4.64%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -232.00M | 36.00M | 434.00M | 373.00M | 338.00M |
| Total Depreciation and Amortization | 649.00M | 635.00M | 627.00M | 618.00M | 622.00M |
| Total Amortization of Deferred Charges | 31.00M | 35.00M | 37.00M | 39.00M | 40.00M |
| Total Other Non-Cash Items | 13.00M | -7.00M | -645.00M | -584.00M | -608.00M |
| Change in Net Operating Assets | 99.00M | -70.00M | 119.00M | 89.00M | 149.00M |
| Cash from Operations | 560.00M | 629.00M | 572.00M | 535.00M | 541.00M |
| Capital Expenditure | -276.00M | -261.00M | -211.00M | -188.00M | -147.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -41.00M | -41.00M | -41.00M | -41.00M |
| Divestitures | 9.00M | 9.00M | 1.30B | 1.30B | 1.36B |
| Other Investing Activities | -12.00M | -12.00M | -11.00M | -11.00M | -14.00M |
| Cash from Investing | -279.00M | -305.00M | 1.04B | 1.06B | 1.16B |
| Total Debt Issued | 2.36B | 540.00M | 600.00M | 720.00M | 570.00M |
| Total Debt Repaid | -2.92B | -850.00M | -2.34B | -2.11B | -2.05B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 288.00M | 21.00M | 268.00M | -23.00M | -17.00M |
| Cash from Financing | -275.00M | -289.00M | -1.48B | -1.41B | -1.49B |
| Foreign Exchange rate Adjustments | 71.00M | -20.00M | -13.00M | -43.00M | -91.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 77.00M | 15.00M | 123.00M | 142.00M | 116.00M |